Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIO market cap is 123.44M. The company's latest EPS is AUD -0.0078 and P/E is -74.36.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.17M | 2.74M | 4.39M | 7.61M | 13.36M |
| Operating Income | -2.61M | -5.31M | -4.5M | -2.98M | -1.58M |
| Net Income | -3.16M | -5.38M | -4.54M | -3.08M | -1.67M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.95M | 2.5M | 8.25M | 7.56M | 8.28M |
| Total Liabilities | 997k | 920k | 1.73M | 3.97M | 5.37M |
| Total Equity | 950k | 1.58M | 6.53M | 3.59M | 2.9M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.22M | -2.39M | -3.42M | -3.5M | -164k |
| Investing | -180k | -29k | -99k | -401k | -22k |
| Financing | 3.37M | 2.58M | 8.4M | 665k | 794k |
| Market Cap | 123.44M |
| Price to Earnings Ratio | -74.36 |
| Price to Sales Ratio | 9.24 |
| Price to Cash Ratio | 42.96 |
| Price to Book Ratio | 42.51 |
| Dividend Yield | - |
| Shares Outstanding | 212.83M |
| Average Volume (1 week) | 571.18k |
| Average Volume (1 Month) | 742.69k |
| 52 Week Change | 383.33% |
| 52 Week High | 0.87 |
| 52 Week Low | 0.115 |
| Spread (Intraday) | 0.05 (7.38%) |
| Company Name | Biome Australia Ltd |
| Address |
16 dovre street melbourne, victoria 3121 |
| Website | https://www.biomeaustralia.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
